ECT Oekotoxikologie GmbH
  • Home
  • About Us
    • Our expertise
    • Management
    • Activities in SETAC
    • Good Laboratory Practice (GLP)
  • Testing
    • Analytical chemistry
    • Aquatic Organisms
    • Sediment Organisms
    • Terrestrial Organisms
    • Dung Organisms
    • Bioaccumulation
    • Environmental Fate
    • Taxonomy
    • Waste
    • Wastewater
  • Consultancy
    • Industrial Chemicals
    • Pharmaceuticals
    • Biocides
    • Plant Protection Products
    • Mixtures
    • Waste
    • Organisation of Workshops & Meetings
    • Training Activities
  • Standardisation
    • OECD activities
    • ISO activities
    • Other standardisation organisations
  • Research
    • Current research projects
    • Projects supported by the European Union (EU)
    • Projects supported by German organisations
    • Projects supported by other organisations
    • All projects
    • Publications
  • News
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu
You are here: Home1 / pharmaceutical

Tag Archive for: pharmaceutical

PREMIER database on environmental risk assessment of pharmaceuticals launched

November 2025

The Innovative Medicines Initiative (IMI) project ‘Prioritisation and risk evaluation of medicines in the environment’ (PREMIER) has launched its database on environmental risk assessment of pharmaceuticals. The PREMIER database is an open platform to support science-based decisions during the assessment of potential risks of pharmaceuticals in the aquatic environment. ECT is involved in PREMIER as […]

Read more →

Publications on pharmaceuticals in the environment

January 2025
Read more →
Prioritisation and risk evaluation of medicines in the environment (PREMIER)Premier

New project started: ‘Prioritisation and risk evaluation of medicines in the environment’ (PREMIER)

March 2021

The Innovative Medicines Initiative (IMI) project PREMIER aims to develop a centralised, user-friendly digital assessment system accessible for all relevant stakeholders. PREMIER will also explore options to incorporate environment considerations earlier in the drug development process to inform drug design and to reduce the need of animal testing. ECT is involved in this project as […]

Read more →
Prioritisation and risk evaluation of medicines in the environment (PREMIER)Premier

Prioritisation and risk evaluation of medicines in the environment (PREMIER)

March 2021

The Innovative Medicines Initiative (IMI) project ‘Prioritisation and risk evaluation of medicines in the environment’ (PREMIER) aims to develop a centralised, user-friendly and transparent digital assessment system accessible for all relevant stakeholders such as regulatory agencies, pharmaceutical industry, water managers and environmental non-governmental organisations. Furthermore, PREMIER will explore the options to incorporate environment considerations earlier […]

Read more →
ECT at SETAC North America 40th Annual MeetingK. Duis

ECT at SETAC North America 40th Annual Meeting

September 2019

The SETAC North America 40th Annual Meeting takes place in Toronto (Canada) from 3 – 7 November 2019. ECT contributes with the following presentation:

Read more →

Joint effects of pharmaceuticals and industrial chemicals from wastewater treatment plant effluents – evaluating concepts for a risk assessment using experimental scenarios

March 2014

The aim of this project is to develop and evaluate concepts for a risk assessment of wastewater effluents taking into account the joint effects of chemicals, which are not completely eliminated in the wastewater treatment process. The focus is on pharmaceutical residues and industrial chemicals, particularly those that are frequently detected in effluents. The predictability […]

Read more →
application of biosolids to land

Ecological impacts of land application of biosolids on soil-dwelling organisms

January 2011

In a long-term experiment run by Agriculture & Agri-Food Canada, the fate of pharmaceuticals and other substances contained in biosolids was followed after farm-scale application to agricultural land on an experimental field site in Ottawa. In the context of this experiment, ECT followed the development of nematode and enchytraeid communities over several years after the […]

Read more →

Environmental risk assessment of pharmaceuticals (ERAPharm)

January 2011

The widespread detection of a large variety of pharmaceuticals in the environment has raised concerns about the potential impact of these bioactive substances on the environment. Although research on the fate and effects of pharmaceuticals in the environment has become an important issue and progressed significantly, a number of uncertainties remained. Therefore, the overall aim […]

Read more →

Find us at

ECT Oekotoxikologie GmbH
Böttgerstraße 2 – 14
65439 Flörsheim am Main
Germany

Phone: +49 6145 9564-0
Fax: +49 6145 9564-99

About ECT

ECT Oekotoxikologie GmbH was founded as a privately owned, independent enterprise in 1993, and joined the SynTech Research Group in November 2021.

In compliance with Good Laboratory Practice (GLP), we perform standardised ecotoxicological tests in the laboratory as well as at semi-field and field level.

An overview of the ecotoxicology services provided by the whole SynTech Research Group is given here.

Recent Posts

  • Renewed approval for R&D activities for private companies
  • Meet ECT and the SynTech Research Group at the SETAC Europe 36th Annual Meeting
  • New publications on the effects of plant protection products on soil organisms

Pages

  • Testing
  • Consultancy
  • Standardisation
  • Research
  • News
  • Jobs
  • About Us

Find us at

ECT Oekotoxikologie GmbH
Böttgerstraße 2 – 14
65439 Flörsheim am Main
Germany

Phone: +49 6145 9564-0
Fax: +49 6145 9564-99

©2011-2026 ECT Oekotoxikologie GmbH. All rights reserved • Webdesign: inspiras Webagentur Frankfurt
  • Home
  • Imprint
  • Privacy Policy
  • Photo credits
Scroll to top Scroll to top Scroll to top